Biostem Investor Relations Material

BioStem Technologies Inc. is a life sciences and regenerative medicine company that focuses on developing, manufacturing, and commercializing placental-derived allografts for advanced wound care. The company uses its proprietary BioRetain process to produce perinatal tissue allografts, preserving key biological properties that support tissue regeneration. BioStem’s products are used in a range of medical applications, including wound management and tissue repair. The company's portfolio includes products such as VENDAJE, VENDAJE AC, and AmnioWrap2. The company is headquartered in Pompano Beach, Florida, and its shares are listed on the OTC market.